CHA-Meditech Co., Ltd. agreed to acquire CHA-BioMed Co. Ltd from CHA Bio&Diostech Inc. (KOSDAQ:A085660) and other sellers in stock on April 21, 2015. The exchange ratio is 1:0.012486. CHA-Meditech Co., Ltd will be surviving entity. CHA-Meditech Co., Ltd. will issue 0.1 million new shares. CHA-Meditech Co., Ltd. entered into contract to acquire CHA-BioMed Co. Ltd from CHA Bio&Diostech Inc. and other sellers on April 22, 2015. The Board of Directors of CHA Bio&Diostech Inc. made a resolution in favor of the transaction on April 21, 2015. The general meeting of stockholders approved the transaction on May 22, 2015.

CHA-Meditech Co., Ltd. completed the acquisition of CHA-BioMed Co. Ltd from CHA Bio&Diostech Inc. (KOSDAQ:A085660) and other sellers on June 30, 2015.